Jemincare Group Co., Ltd

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Regeneron Bolsters Ophthalmic Portfoli

Genentech is to collaborate with Orionis Biosciences to discover and develop new ‘molecular glue’ medicines, a field which is already attracting much big pharma investment. The biotech will receive

The ecosystem between biotech and pharma has never been richer and "it's so interesting to see that symbiosis working so well." So said James Sabry, global head of pharma partnering at Roche Holding

Chinese pharma companies, more established drug makers and biotech start-ups alike, are increasingly looking to license out rights to their product candidates to global partners in an effort to weathe